Human Papillomavirus (HPV) status
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | BIO-HPV-STATUS |
|---|---|
| Type | Biomarker |
| Aliases | HPV genotypeHPV statusp16 IHC (surrogate for HPV in OPC)Статус ВПЛ (вірус папіломи людини) |
| Status | reviewed 2026-04-26 |
| Diseases | None declared |
| Sources | SRC-NCCN-CERVICAL-2025 |
Biomarker Facts
| Biomarker type | serum_marker |
|---|---|
| Measurement | Methodp16 IHC (surrogate for HPV in OPC; >70% nuclear+cytoplasmic positivity = HPV+) AND/OR HPV in-situ hybridization OR HPV DNA PCR genotyping (HR-HPV: 16, 18, 31, 33, 45, 52, 58) Unitscategorical: HPV-positive (and genotype if known) | HPV-negative |
| Related biomarkers | None declared |
Used By
Diseases
DIS-HNSCC- Head and neck squamous cell carcinoma (HNSCC)
Indications
IND-CERVICAL-LOCALLY-ADVANCED-CRT- IND-CERVICAL-LOCALLY-ADVANCED-CRT
Questionnaires
QUEST-CERVICAL-1L-STUB- Cervical carcinoma — first line